Elza Friedländer

699 total citations
7 papers, 530 citations indexed

About

Elza Friedländer is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Elza Friedländer has authored 7 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Elza Friedländer's work include HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Elza Friedländer is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Elza Friedländer collaborates with scholars based in Hungary, Germany and United States. Elza Friedländer's co-authors include Thomas M. Jovin, Péter Nagy, Jorma Isola, Minna Tanner, Kermit L. Carraway, Anita I. Kapanen, György Vereb, János Szöllõsi, Márk Barok and Jeroen van der Laak and has published in prestigious journals such as Cancer Research, American Journal of Clinical Pathology and European Journal of Pharmaceutical Sciences.

In The Last Decade

Elza Friedländer

7 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elza Friedländer Hungary 7 370 293 223 47 40 7 530
Merel Gijsen United Kingdom 9 364 1.0× 222 0.8× 212 1.0× 66 1.4× 50 1.3× 17 540
Ioannis Roxanis United Kingdom 10 306 0.8× 172 0.6× 187 0.8× 88 1.9× 38 0.9× 18 553
Pontus K.E. Börjesson Netherlands 8 189 0.5× 330 1.1× 125 0.6× 118 2.5× 30 0.8× 9 522
Marta Bellone Italy 11 243 0.7× 76 0.3× 147 0.7× 47 1.0× 43 1.1× 18 446
Michael M. Grandal Denmark 8 157 0.4× 136 0.5× 220 1.0× 48 1.0× 25 0.6× 11 375
Sara García‐Alonso Spain 9 364 1.0× 261 0.9× 184 0.8× 59 1.3× 16 0.4× 11 497
G. Rowlinson United Kingdom 7 122 0.3× 285 1.0× 94 0.4× 49 1.0× 22 0.6× 10 435
Emily Capone Italy 16 396 1.1× 223 0.8× 352 1.6× 95 2.0× 19 0.5× 36 723
Martijn Gerretsen Netherlands 9 126 0.3× 196 0.7× 172 0.8× 74 1.6× 28 0.7× 16 477
Katharine C. Lai United States 8 426 1.2× 342 1.2× 175 0.8× 20 0.4× 25 0.6× 17 590

Countries citing papers authored by Elza Friedländer

Since Specialization
Citations

This map shows the geographic impact of Elza Friedländer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elza Friedländer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elza Friedländer more than expected).

Fields of papers citing papers by Elza Friedländer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elza Friedländer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elza Friedländer. The network helps show where Elza Friedländer may publish in the future.

Co-authorship network of co-authors of Elza Friedländer

This figure shows the co-authorship network connecting the top 25 collaborators of Elza Friedländer. A scholar is included among the top collaborators of Elza Friedländer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elza Friedländer. Elza Friedländer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Louzao-Martinez, Laura, Elza Friedländer, Jeroen van der Laak, & Konnie M. Hebeda. (2014). Abundance of IgG4+ Plasma Cells in Isolated Reactive Lymphadenopathy Is No Indication of IgG4-Related Disease. American Journal of Clinical Pathology. 142(4). 459–466. 28 indexed citations
2.
Friedländer, Elza, Márk Barok, János Szöllõsi, & György Vereb. (2008). ErbB-directed immunotherapy: Antibodies in current practice and promising new agents. Immunology Letters. 116(2). 126–140. 53 indexed citations
3.
Friedländer, Elza, György Vereb, András Balla, et al.. (2006). Nucleolar localization of phosphatidylinositol 4‐kinase PI4K230 in various mammalian cells. Cytometry Part A. 69A(12). 1174–1183. 26 indexed citations
4.
Márián, Teréz, et al.. (2006). Na+/Ca2+ exchanger inhibitors modify the accumulation of tumor-diagnostic PET tracers in cancer cells. European Journal of Pharmaceutical Sciences. 30(1). 56–63. 8 indexed citations
5.
Friedländer, Elza, Donna J. Arndt‐Jovin, Péter Nagy, et al.. (2005). Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: Local stimulation using magnetic microspheres as assessed by quantitative digital microscopy. Cytometry Part A. 67A(2). 161–171. 16 indexed citations
6.
Nagy, Péter, Elza Friedländer, Minna Tanner, et al.. (2005). Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line. Cancer Research. 65(2). 473–482. 392 indexed citations
7.
Krasznai, Zoárd Tibor, Elza Friedländer, Gábor Szabó, et al.. (2005). Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer.. PubMed. 25(2A). 1187–92. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026